113 related articles for article (PubMed ID: 1319860)
1. Staging lung carcinoma with a Tc-99m labeled monoclonal antibody.
Vansant JP; Johnson DH; O'Donnell DM; Stewart JR; Sonin AH; McCook BM; Powers TA; Salk DJ; Frist WH; Sandler MP
Clin Nucl Med; 1992 Jun; 17(6):431-8. PubMed ID: 1319860
[TBL] [Abstract][Full Text] [Related]
2. Detection and staging of small cell lung carcinoma with a technetium-labeled monoclonal antibody. A comparison with standard staging methods.
Balaban EP; Walker BS; Cox JV; Bordlee RP; Salk D; Abrams PG; Sheehan RG; Frenkel EP
Clin Nucl Med; 1992 Jun; 17(6):439-45. PubMed ID: 1319861
[TBL] [Abstract][Full Text] [Related]
3. Imaging lung cancer with radiolabeled antibodies.
Breitz HB; Sullivan K; Nelp WB
Semin Nucl Med; 1993 Apr; 23(2):127-32. PubMed ID: 8390098
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
Atasever T; Gündoğdu C; Vural G; Kapucu LO; Karalezli A; Unlü M
Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
[TBL] [Abstract][Full Text] [Related]
5. Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma.
Balaban EP; Walker BS; Cox JV; Sein AA; Abrams PG; Salk D; Sheehan RG; Frenkel EP
Clin Nucl Med; 1991 Oct; 16(10):732-6. PubMed ID: 1660386
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m monoclonal antibody fragment (Fab) scintigraphy in the evaluation of small cell lung cancer: a preliminary report.
Morris JF; Krishnamurthy S; Antonovic R; Duncan C; Turner FE; Krishnamurthy GT
Int J Rad Appl Instrum B; 1991; 18(6):613-20. PubMed ID: 1660451
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
Kairemo KJ; Aronen HJ; Liewendahl K; Paavonen T; Heikkonen JJ; Virkkunen P; Mäki-Hokkonen H; Karonen SL; Brownell AL; Mäntylä MJ
Acta Oncol; 1993; 32(7-8):771-8. PubMed ID: 8305225
[TBL] [Abstract][Full Text] [Related]
8. NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer.
Rusch V; Macapinlac H; Heelan R; Kramer E; Larson S; McCormack P; Burt M; Martini N; Ginsberg R
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):200-4. PubMed ID: 8393504
[TBL] [Abstract][Full Text] [Related]
9. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
10. Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.
Friedman S; Sullivan K; Salk D; Nelp WB; Griep RJ; Johnson DH; Blend MJ; Aye R; Suppers V; Abrams PG
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1069-78. PubMed ID: 1962776
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results.
Kramer EL; Noz ME; Liebes L; Murthy S; Tiu S; Goldenberg DM
Cancer; 1994 Feb; 73(3 Suppl):890-5. PubMed ID: 8306275
[TBL] [Abstract][Full Text] [Related]
12. Thallium-201-chloride and technetium-99m-MIBI SPECT of primary and metastatic lung carcinoma.
Kashitani N; Makihara S; Maeda T; Eda R; Takeyama H; Hiraki Y
Oncol Rep; 1999; 6(1):127-33. PubMed ID: 9864415
[TBL] [Abstract][Full Text] [Related]
13. Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas.
Baum RP; Niesen A; Hertel A; Adams S; Kojouharoff G; Goldenberg DM; Hör G
Cancer; 1994 Feb; 73(3 Suppl):896-9. PubMed ID: 8306276
[TBL] [Abstract][Full Text] [Related]
14. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
Lee HY; Chung JK; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
Ann Nucl Med; 2008 May; 22(4):281-6. PubMed ID: 18535878
[TBL] [Abstract][Full Text] [Related]
15. Contribution of (99m)Tc-depreotide (Neospect) scintigraphy in lung cancer staging.
Karathanos E; Datseris I; Vlontzou E; Zisimopoulos A; Georgiou E
J BUON; 2010; 15(1):147-52. PubMed ID: 20414943
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations.
Macmillan CH; Perkins AC; Wastie ML; Leach IH; Morgan DA
Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288
[TBL] [Abstract][Full Text] [Related]
17. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer.
Schillaci O; Monteleone F; D'Andrea N; Picardi V; Cangemi R; Cangemi V; Scopinaro F
Cancer Biother Radiopharm; 1999 Apr; 14(2):129-34. PubMed ID: 10850296
[TBL] [Abstract][Full Text] [Related]
19. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
Blum J; Handmaker H; Lister-James J; Rinne N
Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805
[TBL] [Abstract][Full Text] [Related]
20. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K
Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
